Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
2008 Dec 15
A Review of Recent Patents on the Protozoan Parasite HSP90 as a Drug Target
Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma
30 mg/kg than 0
259674-19-6
Calcimycin hemimagnesium - CAS# 72124-77-7 Size:Contact [email protected] for quotation 2008 Dec 15Calcimycin (A 23187) hemimagnesium is an antibiotic and a unique divalent cation ionophore (like calcium and magnesium). Calcimycin hemimagnesium induces Ca2+ dependent cell death by increasing intracellular calcium concentration. Calcimycin hemimagnesium inhibits the growth of Gram positive bacteria and some fungi. Calcimycin hemimagnesium also inhibits the activity of ATPase and uncouples oxidative phosphorylation (OXPHOS) of mammalian cells.